You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hydroxyurea Intolerant

Showing 1 - 25 of 725
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023

Ruxolitinib for Polycythemia Vera in Patients Resistant to or

Completed
  • Polycythemia Vera (PV)
  • Ruxolitinib
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Polycythemia Vera Trial in Worldwide (Idasanutlin)

Terminated
Has Results
  • Polycythemia Vera
  • Phoenix, Arizona
  • +10 more
Dec 7, 2021

Polycythemia Vera Trial in China (Ropeginterferon alfa-2b)

Active, not recruiting
  • Polycythemia Vera
  • Ropeginterferon alfa-2b
  • Beijing, China
  • +13 more
Aug 1, 2022

MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib, Anagrelide, Placebo)

Terminated
Has Results
  • MPN (Myeloproliferative Neoplasms)
  • Phoenix, Arizona
  • +25 more
Oct 21, 2021

Essential Thrombocythemia Trial in Tours (Anagrelide, Ruxolitinib (JAKAVI®), IFNa/ PegIFNa)

Terminated
  • Essential Thrombocythemia
  • Tours, France
    FILO
Jun 28, 2021

Polycythemia Vera Trial in Worldwide (Best Available Therapy, Ruxolitinib)

Completed
Has Results
  • Polycythemia Vera
  • Herston, Queensland, Australia
  • +47 more
Jun 29, 2021

Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

Recruiting
  • Sickle Cell Disease
  • Allogeneic Non-Myeloablative Stem Cell Transplantation
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Feb 16, 2022

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Study Conducted Among Patients With CML

Completed
  • Chronic Myeloid Leukemia
  • Tyrosine Kinase Inhibitors (TKIs)
  • East Hanover, New Jersey
    Novartis Investigative Site
Jul 25, 2022

Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

Completed
  • Thalassemia, Beta
  • Hydroxyurea and Thalidomide
  • Karachi, Sindh, Pakistan
    Children's Hospital Karachi
Nov 23, 2023

Sickle Cell Disease Trial in Jinja (Hydroxyurea)

Recruiting
  • Sickle Cell Disease
  • Jinja, Uganda
    Jinja Regional Referral Hospital (JRRH), Department of Paediatri
Dec 14, 2022

Polycythemia Vera Trial in Worldwide (Ruxolitinib)

Completed
Has Results
  • Polycythemia Vera
  • Linz, Austria
  • +64 more
Jul 16, 2019

Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)

Not yet recruiting
  • Polycythemia Vera
  • Givinostat Hydrochloride
  • Hydroxy Urea
  • (no location specified)
Oct 19, 2023

Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Sickle Cell Anemia Trial in Kingston (Hydroxyurea)

Recruiting
  • Sickle Cell Anemia
  • Kingston, Jamaica
    Sickle Cell Unit
Jan 20, 2023

Sickle Cell Disease Trial in United States (InCharge Health mobile application, HU Toolbox mobile application)

Completed
  • Sickle Cell Disease
  • InCharge Health mobile application
  • HU Toolbox mobile application
  • Augusta, Georgia
  • +6 more
Sep 26, 2022

Polycythemia Vera Trial in Worldwide (ruxolitinib tablets, Best Available Therapy (BAT))

Completed
Has Results
  • Polycythemia Vera
  • ruxolitinib tablets
  • Best Available Therapy (BAT)
  • Birmingham, Alabama
  • +101 more
Feb 8, 2019

PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

Not yet recruiting
  • PCNSL
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jun 8, 2023

Hypercholesterolemia Trial in Japan (K-877 0.2 mg/day (once daily), K-877 0.4 mg/day (once daily), Placebo (once daily))

Recruiting
  • Hypercholesterolemia
  • K-877 0.2 mg/day (once daily)
  • +2 more
  • Aichi, Japan
  • +14 more
Jun 20, 2023

Sickle Cell Anemia in Children, Sickle Cell Disease Trial in Luanda (Hydroxyurea)

Not yet recruiting
  • Sickle Cell Anemia in Children
  • Sickle Cell Disease
  • Luanda, Angola
    Hospital Geral dos Cajueiros
Jan 26, 2023

Sickle-Cell Anaemia Trial in Kinshasa (Hydroxyurea)

Completed
  • Sickle-Cell Anaemia
  • Kinshasa, Congo, The Democratic Republic of the
    University of Kinshasa
Dec 27, 2022

Priapism Due to Sickle Cell Disease Trial in Kano (Tadalafil, Hydroxyurea, Placebo)

Recruiting
  • Priapism Due to Sickle Cell Disease
  • Kano, Nigeria
  • +1 more
Aug 23, 2022

Sickle Cell Anemia in Children Trial in Kampala (Hydroxyurea)

Active, not recruiting
  • Sickle Cell Anemia in Children
  • Kampala, Uganda
    Global Health Uganda
May 11, 2022